T. Rowe Price Investment Management, Inc. Abbott Laboratories Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 17,769,095 shares of ABT stock, worth $2.31 Billion. This represents 1.45% of its overall portfolio holdings.
Number of Shares
17,769,095
Previous 8,366,739
112.38%
Holding current value
$2.31 Billion
Previous $1.14 Billion
109.15%
% of portfolio
1.45%
Previous 0.72%
Shares
10 transactions
Others Institutions Holding ABT
# of Institutions
3,649Shares Held
1.38BCall Options Held
10.4MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...